Review Timeline | CrossMark Policy | ClinMed Features
logo
International Journal of
Stem Cell Research & Therapy ISSN: 2469-570X

Citation

Vaquero J, Zurita M, Mucientes J, Rodríguez-Boto G, Fernández-Mateos C (2018) Transplantation of Autologous Bone Marrow-Derived Stromal Cells into Injured Spinal Cord Enhances Glucose Metabolism and Promotes Functional Recovery. Int J Stem Cell Res Ther 5:057. doi.org/10.23937/2469-570X/1410057

Copyright

© 2018 Vaquero J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

CASE REPORT | OPEN ACCESSDOI: 10.23937/2469-570X/1410057

Transplantation of Autologous Bone Marrow-Derived Stromal Cells into Injured Spinal Cord Enhances Glucose Metabolism and Promotes Functional Recovery

Jesús Vaquero1*, Mercedes Zurita1, Jorge Mucientes2, Gregorio Rodríguez-Boto1 and Cecilia Fernández-Mateos1

1Service of Neurosurgery, Puerta de Hierro-Majadahonda Hospital, Autonomous University, Spain

2Service of Nuclear Medicine, Puerta de Hierro-Majadahonda Hospital, Autonomous University, Spain

Abstract

The authors report the case of a 40-year-old man who suffered paraplegia from 2013, due to shot by firearm. In april 2017 he underwent cell therapy consisting of administration of autologous bone marrow stromal cells (BMSCs) into injured spinal cord and subarachnoid space by lumbar puncture. Throughout one year of follow-up, the patient experienced clear improvement in sensitivity, motor, and sphincter functions. After BMSCs administration, studies with 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) suggested an enhancement in glucose uptake at level of injured spinal cord, at least in the course or the first 6 months after the start of cell therapy. This case supports previous observations about the improvements obtained by cell therapy with autologous BMSCs in chronic paraplegic patients, and suggests that a possible increase in tissue metabolism, mediated by the presence of BMSCs into injured spinal cord, can be one of the causes of early clinical improvements.